Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA)

Hormone and Metabolic Research

Volumn 40, Issue 1, 2008, Pages 56-59

  Leifke, E ^a,d   Kinzel, M ^a   Tsikas, D ^a   Gooren, L ^b   Frolich J C ^a   Brabant, G ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Hopital Manchester Centre Hospitalier de Charleville Mezieres   (France)

^d TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Asymmetric dimethylarginine (ADMA); Cardiovascular risk; Endothelial dysfunction; Male hypogonadism; Nitric oxide; Testosterone

Indexed keywords

N(G),N(G) DIMETHYLARGININE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPOGONADISM; MALE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; URINARY EXCRETION;

ADULT; AGED; ARGININE; BODY MASS INDEX; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; NITRATES; NITRITES; TESTOSTERONE;

EID: 38849160036     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004529     Document Type: Article

References (29)

1. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006; 38: 126-136
2. Han SH, Quon MJ, Koh KK. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. Curr Opin Lipidol 2007; 18: 58-65
3. Di Marzio D, Mohn A, Martino A de, Chiarelli F. Macroangiopathy in Adults and Children with Diabetes: From Molecular Mechanisms to Vascular Damage (Part 1). Horm Metab Res 2006; 38: 691-705
4. Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2006; 2: 209-220
5. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (Suppl 12): S60-S62
6. Zoccali C. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens 2006; 24: 611-619
7. Teerlink T. ADMA metabolism and clearance. Vasc Med 2005; 10 (Suppl 1): S73-S81
8. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003; 23: 1455-1459
9. Cakir E, Ozcan O, Yaman H, Akgul EO, Bilgi C, Erbil MK, Yesilova Z. Elevated plasma concentration of asymmetric dimethylarginine that is reduced by single dose testosterone administration in idiopathic hypogonadotropic hypogonadism patients. J Clin Endocrinol Metab 2005; 90: 1651-1654
10. Svartberg J. Epidemiology: testosterone and the metabolic syndrome. Int J Impot Res 2007; 19: 124-128
11. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288-1299
12. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 2006; 290: E234-E42
13. Sader MA, Griffiths KA, Skilton MR, Wishart SM, Handelsman DJ, Celermajer DS. Physiological testosterone replacement and arterial endothelial function in men. Clin Endocrinol (Oxf) 2003; 59: 62-67
14. Zitzmann M, Brune M, Nieschlag E. Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocrinol Metab 2002; 87: 5030-5037
15. Kuehnert B, Byrne M, Simoni M, Koepke W, Gerss J, Lemmnitz G, Nieschlag E, for the Wolff Multi-Centre Study Group. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Eur J Endocrinol 2005; 153(2): 317-326
16. Vermeulen A, Verdonck L, Kaufman J. A critical evaluation of simple methods for the estimation of free testosterone in serum. Clin Endocrinol Metab 1999; 84: 3666-3672
17. Tsikas D, Gutzki FM, Stichtenoth DO. Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis. Eur J Clin Pharmacol 2006; 62 (Suppl 13): 51-59
18. Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frolich JC. Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 798: 87-99
19. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal Chem 2000; 72: 4064-4072
20. Tsikas D, Wolf A, Frolich JC. Simplified HPLC method for urinary and circulating creatinine. Clin Chem 2004; 50: 201-203
21. Valtonen P, Karppi J, Nyyssonen K, Valkonen VP, Halonen T, Punnonen K. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 828: 97-102
22. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GS, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996; 119: 1533-1540
23. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocrinol Rev 2003; 24: 313-340
24. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27: 1036-1041
25. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358: 2127-2128
26. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clin Chem Lab Med 2005; 43: 1130-1138
27. Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 2004; 94: 157-161
28. Di Marzio D, Mohn A, Martino A de, Chiarelli F. Macroangiopathy in Adults and Children with Diabetes: Risk factors (Part 2). Horm Metab Res 2006; 38: 706-720
29. Grillo ML, Jacobus AP, Scalco R, Amaral F, Rodrigues DO, Loss ES, Wassermann GF. Testosterone rapidly stimulates insulin release from isolated pancreatic islets through a non-genomic dependent mechanism. Horm Metabol Res 2005; 37: 662-665